N-Farnesyloxy-norcantharimide inhibits progression of human leukemic Jurkat T cells through regulation of mitogen-activated protein kinase and interleukin-2 production-Reference-Cited by-同舟云学术

N-Farnesyloxy-norcantharimide inhibits progression of human leukemic Jurkat T cells through regulation of mitogen-activated protein kinase and interleukin-2 production

Published:2015-11 Issue:10 Volume:26 Page:1034-1042
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Chang Ming-Che,Wu Jin-Yi,Liao Hui-Fen,Chen Yu-Jen,Kuo Cheng-Deng

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference46 articles.

1. Medical uses of mylabris in ancient China and recent studies.;Wang;J Ethnopharmacol,1989

2. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells.;Chen;Int J Cancer,2002

3. Inhibitory effect of norcantharidin, a derivative compound from blister beetles, on tumor invasion and metastasis in CT26 colorectal adenocarcinoma cells.;Chen;Anticancer Drugs,2005

4. A small-molecule metastasis inhibitor, norcantharidin, downregulates matrix metalloproteinase-9 expression by inhibiting Sp1 transcriptional activity in colorectal cancer cells.;Chen;Chem Biol Interact,2009

5. Cantharidin, another natural toxin that inhibits the activity of serinethreonine protein phosphatases types 1 and 2A.;Honkanen;FEBS Lett,1993

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temperature Dependence of Membrane Permeability Parameters for Five Cell Types Using Nonideal Thermodynamic Assumptions to Mathematically Model Cryopreservation Protocols;The Journal of Physical Chemistry B;2024-01-31

2. Strategies for Solubility and Bioavailability Enhancement and Toxicity Reduction of Norcantharidin;Molecules;2022-11-10

3. Insight into norcantharidin, a small-molecule synthetic compound with potential multi-target anticancer activities;Chinese Medicine;2020-05-29

4. Determination of the Membrane Transport Properties of Jurkat Cells with a Microfluidic Device;Micromachines;2019-11-29

5. Inhibitory effect of berberine on interleukin-2 secretion from PHA-treated lymphocytic Jurkat cells;International Immunopharmacology;2019-01